Lymphoid Neoplasias II Clinical and Therapeutic Aspects

We have studied 24 cases of secondarily leukemic (stage V) lymphosarcoma (LS), 31 cases of "d'emblee" leukemic LS, and ten cases of lymphoid leukemic neoplasias transitional between "d'emblee" leukemic LS and chronic lymphocytic leukemia (eLL). These cases only concern...

Full description

Bibliographic Details
Other Authors: Mathe, G. (Editor), Seligmann, M. (Editor), Tubiana, M. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1978, 1978
Edition:1st ed. 1978
Series:Recent Results in Cancer Research
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • I: Clinical Aspects: Staging and Therapeutic Implications
  • Introductory Remarks
  • Cellular Renewal Kinetics of Malignant Non-Hodgkin’s Lymphomas
  • Clinical Staging and New Therapeutic Approaches in Multiple Myeloma
  • Staging of Myeloma. A Preliminary Study of Staging Factors and Treatment in Different Stages
  • Prognostic Factors and Treatment of Multiple Myeloma: Interest of a Cyclic Sequential Chemohormonotherapy Combining Cyclophosphamide, Melphalan, and Prednisone
  • Pathological Staging in Adult Previously Untreated Non-Hodgkin’s Lymphomas
  • Staging in Adult Non-Hodgkin’s Lymphomas
  • Invasion of the Upper Respiratory and Digestive Tract in Adult Lymphoid Neoplasias
  • Non-Hodgkin’s Lymphoma of the Upper Digestive and Respiratory Tract: Histopathology and Implications for Treatment
  • Staging in Childhood Non-Hodgkin’s Lymphoma. What Are Its Benefits? How Extensive Should It Be?
  • Systematic Restaging in Non-Hodgkin’s Lymphoma: The Need to Define Complete Remission
  • Involvement of the Nervous System in Non-Hodgkin’s Lymphomas
  • Leukemic (or Stage V) Lymphosarcoma
  • Comments on “Clinical Aspects: Staging and Therapeutic Implications”
  • II: Treatment of Non-Hodgkin’s Lymphomas
  • Radiotherapy of Extranodal Non-Hodgkin’s Lymphoma
  • Evaluation and Role of Single Chemotherapeutic Agents in Adult Non-Hodgkin’s Lymphoma
  • General Strategy of Staging and Therapy of Non- Hodgkin’s Lymphomas
  • Chemotherapy in Non-Hodgkin’s Malignant Lymphomas According to Potential Evolutive Groups
  • BCG in the Immunotherapy of Non-Hodgkin’s Malignant Lymphomas: Preliminary Results of a Controlled Trial
  • Chemoimmunotherapy Versus Chemotherapy for Remission Induction in Patients With Non-Hodgkin’s Lymphoma: Progress Report of a Southwest Oncology Group Study.-Complications of Total Abdominal and Spleen Irradiation in Patients With Lymphomas
  • Effects of Treatment of Malignant Lymphomas on the Granulocytic Progenitor Cells (CFUc)
  • Preliminary Results of Chemoradiotherapy Followed (or Not) by Active Immunotherapy of Stage III and IV Lymphosarcoma and Reticulosarcoma: Correlation of the Results With WHO Categorization
  • Outline of a Prospective Multicentric Study on the Clinical Significance of the Kiel Classification of Non-Hodgkin’s Lymphomas
  • On the Question of the Tumoricidal Dose in Non-Hodgkin’s Lymphomas
  • Combined Modality Therapy of Childhood Non-Hodgkin’s Lymphoma
  • Concluding Remarks on Malignant Lymphomas